Metformin Mediated PD‐L1 Downregulation in Combination with Photodynamic‐Immunotherapy for Treatment of Breast Cancer-Reference-Cited by-同舟云学术

Metformin Mediated PD‐L1 Downregulation in Combination with Photodynamic‐Immunotherapy for Treatment of Breast Cancer

Published:2021-01-04 Issue:11 Volume:31 Page:2007149
ISSN:1616-301X
Container-title:Advanced Functional Materials
language:en
Short-container-title:Adv. Funct. Mater.

Author:

Hu Chuan¹,He Xueqin¹,Chen Yuxiu¹,Yang Xiaotong¹,Qin Lin¹,Lei Ting¹,Zhou Yang¹,Gong Tao¹,Huang Yuan¹,Gao Huile¹^ORCID

Affiliation:

1. Key Laboratory of Drug‐Targeting and Drug Delivery System of the Education Ministry Sichuan Engineering Laboratory for Plant‐Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology West China School of Pharmacy Sichuan University No. 17, Block 3, Southern Renmin Road Chengdu 610041 P. R. China

Funder

National Natural Science Foundation of China

Fundamental Research Funds for the Central Universities

Publisher

Wiley

Subject

Electrochemistry,Condensed Matter Physics,Biomaterials,Electronic, Optical and Magnetic Materials

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adfm.202007149

Reference31 articles.

1. Cancer immunotherapy comes of age

2. CTLA-4 and PD-1 Pathway Blockade: Combinations in the Clinic